Moderna's COVID-19 Vaccine Candidate To Enter Phase 3 Trial

Newsy

15 Jul 2020 0 shares 1 views

Moderna's COVID-19 Vaccine Candidate To Enter Phase 3 Trial

Moderna's COVID-19 Vaccine Candidate To Enter Phase 3 Trial

Newsy

Published 15 Jul 2020

Watch VideoOne company says it's on track to continue its COVID-19 vaccine candidate trial after it produced "robust" antibody results.

On Tuesday, Moderna released findings from its preliminary vaccine trials. The company said after administering the vaccine to 45 people in the trial, all of them produced antibodies that...

You might like

Related news coverage

How Do Vaccine Trials Get Their Volunteer Testers?

How Do Vaccine Trials Get Their Volunteer Testers?

Newsy 31 Jul 2020

Watch VideoJennifer Haller of Seattle is proud to be the first American to ever get a potential COVID-19..

Is Coronavirus Vaccine Made From Fetal Cell Lines?

Is Coronavirus Vaccine Made From Fetal Cell Lines?

Eurasia Review

29 Jul 2020

Is the coronavirus vaccine made from fetal cell lines?

CNA

28 Jul 2020

Moderna begins phase-3 clinical trial of Covid vaccine in US
Mid-Day 28 Jul 2020
MRNA, PFE/BNTX COVID-19 Vaccines Move Into Phase 3, CytoDyn On Watch, GNCA To Report Data On Jul.30
RTTNews 28 Jul 2020

Advertisement

More coverage

Largest COVID-19 Vaccine Trial Underway

Largest COVID-19 Vaccine Trial Underway

Newsy 27 Jul 2020

Watch VideoThe biggest COVID-19 vaccine study is underway. This week, researchers began testing 30,000 test subjects in the..

Moderna Begins Phase 3 Of Its COVID-19 Vaccine Trial

Moderna Begins Phase 3 Of Its COVID-19 Vaccine Trial

Newsy

27 Jul 2020

Serum Institute Conducts Phase 3 Clinical Trial Of BCG Vaccine

Mid-Day

28 Jul 2020

Moderna begins first late-stage US trial of Covid vaccine
FT.com 27 Jul 2020
Moderna Starts Phase 3 Clinical Trial of Its Coronavirus Vaccine Candidate
Motley Fool 27 Jul 2020